Obesity is a global epidemic and there's a critical need for ideal solutions. Obesity can be considered as a type of medical condition that can be treated with drugs, similar to other major medical conditions such as diabetes and hypertension. Adults with a minimum BMI or body max index of 30 and adults with a minimum BMI of 27 coupled with any obesity diseases related to it, such as hypertension and diabetes, can make use of it.
Some medicines help in suppressing appetite. It is used along with exercise and diet to treat obesity. Sometimes, it is also used to treat obesity that can be related to high blood pressure, high cholesterol, or diabetes. With a few months of consuming it, people can expect a visible result. Lorcaserin has been available within the US region for numerous years, with a name Belviq many know. However, it is still not approved to be used in Europe.
The new powder lorcaserin (Belviq) by AASraw claims to give people a promising result with regards to their obesity problem. With the aim of helping individuals lose excess fats and achieve the body they want, they made lorcaserin powder as one of the best solutions.
Coupled by its effectivity is the claim of a new study (published in the New England Journal of Medicine) that lorcaserin drugs already helped obese people lost an average of 4 kilograms or 8.8 pounds for more than 40 months. A bit long though, but worth the wait.
In the meantime, the drug may only best to use cautiously as per individual patient's needs, especially those with congestive heart failure because it has not been studied in patients with serious heart disease. There are side effects people may encounter, like fatigue, dizziness, headache, nausea, and diarrhea. Although, these side effects might only occur seldom.
Media Contact
Company Name: Aasraw Biochemical Technology Co., Ltd
Contact Person: DR.king
Email: Send Email
Phone: +86 13204026693
Address:1838 Fairway Cir Dr
City: San Marcos
State: CA
Country: United States
Website: http://www.aasraw.com
Source: www.abnewswire.com
